Adrenaline by intravenous infusion is widely used in intensive care for a number of indications. It is an alpha-adrenergic receptor agonist and thus has potent vasoconstrictor activity. We describe what we believe to be the first reported case of accidental infusion of adrenaline into an artery. We discuss the physiological effects of intra-arterial adrenaline and the need for confirmation of correct venous placement of vascular catheters before administering agents with infusion pumps.
CASE REPORT
A 66-year-old 59 kg woman with a long history of severe asthma was admitted to our intensive care unit with acute severe asthma requiring intubation and mechanical ventilation. Her treatment included an intravenous adrenaline infusion. Her bronchospasm remained severe with only minor improvement over the ensuing five days.
On day 5 of her admission she developed septic shock with acute renal failure and disseminated intravascular coagulation. As the source of her sepsis was unknown, a septic screen was performed and all invasive lines were changed. In particular, the left internal jugular central venous catheter was removed and an Arrow triple-lumen catheter (Arrow International Inc, Reading, Pennsylvania) was inserted into what was believed to be the right femoral vein. There was some difficulty noted at insertion due to the patient's obesity and generalized oedema. The adrenaline infusion, delivered via a Terumo syringe driver (Terumo Corporation, Tokyo, Japan), was transferred from the jugular to the femoral catheter and continued at the same rate of 0.50 {tg/kg/min. The infusion contained 3 mg of adrenaline in 47 ml of 0.91tJo saline (i.e. the concentration was 60 {tg/ml). No significant haemodynamic alterations were noted at that time (although a retrospective review of the chart revealed a fall of mean arterial pressure of 5 to 10 mmHg for the ensuing hour) and the adrenaline was continued unchanged. The patient was reviewed approximately 110 minutes later at the morning ward round and the right leg was noted to be cool, mottled and pulseless, with an obvious difference in perfusion of the two legs. The femoral line was connected to a pressure transducer which showed the same pressure recording as the radial arterial line, confirming intra-arterial placement. By this stage approximately 3300 {tg of adrenaline had been infused into the femoral artery. The adrenaline infusion was immediately changed to a venous line. This change from arterial to venous administration was associated in a rise in mean systemic arterial pressure from 60 to 73 mmHg with heart rate stable at approximately 130 beats per minute.
No specific therapy was given and over the ensuing 15-20 minutes the limb's perfusion improved so that there was no clinically detectable difference between the two legs. The catheter was subsequently removed from the femoral artery. There were no adverse sequelae in the right leg and subsequent Doppler ultrasound interrogation showed normal arterial anatomy and flow.
DISCUSSION
Intra-arterial administration of adrenaline is an uncommon incident in the clinical situation. The major concern in such a situation is the well-known vasoconstrictor activity of adrenaline' and the potential for generating vasospasm and peripheral tissue ischaemia'. A Medline search revealed no report of accidental intraarterial adrenaline infusion. Roberts et aP described a case of injection of a bolus of adrenaline into the brachial artery during cardiac arrest. They infused phentolamine via the arterial catheter and reported return of perfusion to the arm over 20 minutes without Anaesthesia and Intensive Care, Vol. 23, No. 4, August, 1995 any ischaemic sequelae. We administered no specific therapy to our patient and observed a similarly rapid return of normal perfusion without adverse sequelae.
Our patient's steroid therapy may have decreased the tissue injury related to ischaemia, but conversely, hydrocortisone has been shown to increase catecholamine-induced vasoconstriction". It should also be noted that the limb per fusion returned to normal on cessation of the intra-arterial infusion of adrenaline, before removal of the catheter. Thus the limb ischaemia resulted from the adrenaline and not the presence of the catheter in the artery.
Serious sequelae following arterial injection of drugs usually result from agents which are locally irritant to the endothelium (e.g. sodium thiopentone'). Adrenaline does not appear to have such local toxicity and in the case described its vascular effects were completely reversible. The rapid recovery of perfusion is consistent with the short biological half-life of adrenaline of 1-2 minutes 6
•
The major vascular site of action of adrenaline is stated to be at the small arterioles and precapillary sphincters'. However our patient had absent major peripheral arterial pulses in the leg while adrenaline was infused into the artery and these pulses rapidly returned when the infusion was ceased. Thus there must have been total, or near-total, occlusion of the major arteries of the leg by vascular smooth muscle spasm in response to exposure of the arteries to high concentrations of adrenaline.
The change from intra-arterial to intravenous adrenaline infusion resulted in a 22070 rise in mean arterial pressure. This implies decreased systemic delivery of the drug when administered via an artery secondary to peripheral tissue uptake or metabolism. This is compatible with previous studies which have shown 27-51% extraction of adrenaline across the forearm in humans 7 ,8 and 70-95% extraction across the hindquarters in animals 9 • The femoral vein is a common site for central venous access'o. It has a number of advantages, including easily obtained landmarks and negation of the risk of pneumothorax (of particular importance in cases of severe asthma such as that described). Stated disadvantages are the risk of deep venous thrombosis and line sepsis, although these risks do not appear to be as high as previously thought"-13 • A contraindication to its use is absence of a palpable femoral arterial pulse, as this is the pivotal landmark for location of the vein. Inadvertent arterial puncture is not uncommon but is usually readily diagnosed clinically. However this was not achieved in the case described and resulted in arterial administration of an agent which was potentially injurious to arteries and may have led to Anaesthesia and Intensive Care, Vol. 23, No. 4, August, 1995 thrombosis and distal ischaemia. This possibility mandates confirmation of venous placement by either pressure transduction or connection to a passive fluid delivery system (as opposed to an infusion pump). It must be emphasized that infusion pumps will deliver fluid into an artery or almost any tissue so that correct intravenous placement of vascular catheters must be confirmed prior to utilizing such active delivery systems.
In summary, this case demonstrates the absolute necessity for confirming correct intravenous placement of central venous catheters before they are used for administration of drugs. It also demonstrates that intra-arterial administration of adrenaline results in decreased haemodynamic effect due to peripheral tissue uptake or metabolism of drug. Although intra-arterial infusion of adrenaline is dangerous it may not result in catastrophic ischaemic sequelae if detected early.
